*NEW* Graduate Certificate in Connected Care: Telehealth & Digital Health Innovation. Courses will begin on August 24, 2020. Apply Today!
This one-of-a-kind certificate will equip students with an understanding of analytical methodologies for the identification and interpretation of cannabis and cannabinoid products.
This first-of-its-kind certificate in Cannabinoid Pharmacology is aimed at teaching the mechanisms of drug action and aspects of pharmacokinetics as it relates to cannabis.
Designed for clinicians to provide an understanding of the science underlying endocannabinoids, phytocannabinoids, and synthetic cannabinoids and their clinical applications.
A combination of didactic and clinical experience, students will be prepared to become Certified Clinical Medical Assistants.
ECMO is a modified heart-lung machine that does the work of the heart and lungs allowing the organs to rest. Understand basic principles, indications and management for ECMO support.
Designed for healthcare professionals seeking the latest evidence on nutrition, diets, and the impact of food on general health.
This program will train participants to safely operate the heart and lung machine, and other advanced technologies, during surgical procedures where patients need cardiac and pulmonary support.
Developed by Emergency Medicine faculty and the National Academic Center for Telehealth, Jefferson’s program prepares the learner for the role of Telehealth Facilitator on the interprofessional healthcare team.
To empower healthcare leaders with data driven strategies using emerging technologies to develop patient solutions.
Brings a new dynamic to professional healthcare education, focusing on mind-body strategies to reduce stress and improve health-related quailty of life.
The Center for Digital Health plays a pivotal role in the promotion, resourcing, design and coordination of clinical and evaluative digital health research at Jefferson.
The mission is to advance the scientific basis, research efforts, educational opportunities, positive social impact opportunities, and patient experience associated with the clinical use of cannabis-derived therapies.